SCHEMBL5332682

SCHEMBL5332682

CC(=O)c1cc(F)c(N)c(I)c1.CC(=O)c1ccc(N)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 5/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ PRKCI P41743 1/20 0.41
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA3 P07451 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CREBBP Q92793 1/20 0.38
▸ SLC6A5 Q9Y345 1/20 0.37
▸ HDAC2 Q92769 3/20 0.35
▸ HDAC3 O15379 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ KIF11 P52732 1/20 0.34
▸ CTSL P07711 1/20 0.34
▸ CTSS P25774 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2946706 0.89 CA1 (0.46) HDAC1HDAC6PRKCICA1CA2
SCHEMBL29388181 0.85 HDAC1 (0.61) HDAC1HDAC6PRKCICA1CA2
SCHEMBL478933 0.85 HDAC1 (0.61) HDAC1HDAC6PRKCICA1CA2
SCHEMBL29659932 0.78 PRKCI (0.52) PRKCICA1CA2CA9CREBBP
SCHEMBL1854564 0.78 PRKCI (0.52) PRKCICA1CA2CA9CREBBP
SCHEMBL22982377 0.76 CA5A (0.46) PRKCICA1CA2CA9CREBBP
SCHEMBL3777767 0.76 HDAC1 (0.57) HDAC1HDAC6PRKCICREBBPMAPT
Hydrochloric Acid SCHEMBL31570673 0.73 HDAC1 (0.46) HDAC1HDAC6PRKCICREBBPHDAC2
SCHEMBL16042892 0.73 CA1 (0.47) HDAC1HDAC6CA1CA2CA3
SCHEMBL16064373 0.73 TPMT (0.54) HDAC1HDAC6CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007142426-A1 NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2007-12-13 — — WO disclosed
EP-1861357-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2007-12-05 — — EP disclosed
WO-2006101318-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-28 — — WO disclosed
Send feedback